Resistance to radiotherapy in breast cancer is also facilitated by the cytokine IL-6, which is recognized for its pro-inflammatory properties and is overexpressed in numerous cancers, especially by adipocytes associated with breast cancer [140]. Here, IL6 is linked to breast carcinoma.